PharmaShots | Incisive News in 3 Shots

Subscribe Now

NGM Bio

NGM Bio’s NGM621 Receives the US FDA’s Fast Track Designation for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration

NGM Bio’s NGM621 Receives the US FDA’s Fast Track Designation for the Treatment of Geographic Atrophy Secondary to Age-Related Mac...

February 8, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us